Compass Ion Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$380K Sell
914
-22
-2% -$8.15K 0.03% 217
2026
Q1
$253K Sell
936
-71
-7% -$21.1K 0.02% 244
2025
Q4
$332K Sell
1,007
-135
-12% -$45.8K 0.03% 208
2025
Q3
$394K Buy
1,142
+21
+2% +$6.35K 0.04% 198
2025
Q2
$350K Buy
1,121
+417
+59% +$159K 0.04% 199
2025
Q1
$369K Buy
704
+98
+16% +$50.1K 0.04% 191
2024
Q4
$307K Buy
606
+5
+0.8% +$2.84K 0.04% 205
2024
Q3
$351K Buy
601
+32
+6% +$18.1K 0.04% 198
2024
Q2
$282K Hold
569
– – 0.04% 193
2024
Q1
$282K Sell
569
-19
-3% -$9.66K 0.04% 193
2023
Q4
$310K Sell
588
-26
-4% -$13.9K 0.05% 181
2023
Q3
$310K Buy
+614
New +$302K 0.05% 176

Other funds holding UNH

Compass Ion Advisors's UNH Position: Q2 2026 in Review

Compass Ion Advisors reduced its UnitedHealth (UNH) stake by 2.4% in Q2 2026, selling an estimated $8.15K and leaving 914 shares worth $380K. The position accounts for 0.03% of the portfolio, ranked #217.

Compass Ion Advisors first reported a position in UNH in Q3 2023 and has held it in 12 quarters since. The position peaked at $394K in Q3 2025. 3,394 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Compass Ion Advisors held 914 shares of UnitedHealth worth $380K as of Q2 2026.
  • Compass Ion Advisors sold 22 UnitedHealth shares in Q2 2026, an estimated $8.15K.
  • UnitedHealth made up 0.03% of Compass Ion Advisors's portfolio in Q2 2026, its #217 holding.
  • Compass Ion Advisors first reported a position in UnitedHealth in Q3 2023 and has held it in 12 quarters since.
  • Compass Ion Advisors's UnitedHealth position peaked at $394K in Q3 2025.
  • 3,394 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Compass Ion Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.